A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Chemical ID:
MESH:D000082
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[Acetaminophen results in increased activity of CYP2E1 protein] inhibits the reaction [PPARA protein results in increased oxidation of Fatty Acids]; [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2E1 mRNA; [IL33 protein affects the susceptibility to Acetaminophen] which affects the expression of CYP2E1 mRNA; Acetaminophen results in increased expression of and results in decreased activity of CYP2E1 protein; Acetaminophen results in increased expression of and results in increased activity of CYP2E1 protein; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; Carnosine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein]; Curcumin inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Curcumin inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; Curcumin metabolite inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Curcumin metabolite inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; Curcumin metabolite promotes the reaction [Acetaminophen results in decreased activity of CYP2E1 protein]; CYP2E1 protein affects the metabolism of and results in decreased abundance of Acetaminophen; CYP2E1 protein affects the reaction [Acetaminophen results in increased abundance of acylcarnitine]; CYP2E1 protein affects the reaction [Acetaminophen results in increased activity of PPARA protein]; CYP2E1 protein results in increased metabolism of and affects the susceptibility to Acetaminophen; CYP2E1 protein results in increased metabolism of and results in increased activity of Acetaminophen; dioscin inhibits the reaction [Acetaminophen results in increased expression of and results in increased activity of CYP2E1 protein]; Genistein inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein]; hyperoside inhibits the reaction [Acetaminophen results in decreased activity of CYP2E1 protein]; IL1A protein inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; Irbesartan inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; KITL protein inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP2E1 mRNA]; PPARA protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein]; Saint John's wort extract inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein]; schizandrol B inhibits the reaction [CYP2E1 protein results in increased metabolism of and results in increased activity of Acetaminophen]; SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Taurine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein]; Taurine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; tetrahydrocurcumin inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; tetrahydrocurcumin inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]
[CYP2E1 protein co-treated with CYP1A2 protein] results in increased susceptibility to Acetaminophen; Ethanol affects the reaction [CYP2E1 protein results in increased susceptibility to Acetaminophen]; GSTM1 protein inhibits the reaction [[CYP2E1 protein co-treated with CYP1A2 protein] results in increased susceptibility to Acetaminophen]; Oxygen deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; PPP2CA protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; PPP2R5A protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; PPP2R5A protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 protein]
[Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2E1 mRNA; [Isoniazid results in increased expression of CYP2E1] which results in increased metabolism of Acetaminophen; Acetaminophen results in increased expression of and results in increased activity of CYP2E1 protein; Acetaminophen results in increased phosphorylation of and results in increased activity of CYP2E1 protein; Arsenic inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein]; Choline deficiency promotes the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; Curcumin inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Uranium analog promotes the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; YH 439 inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of CYP2E1 protein]